Authors:
SCHILLER G
NIMER S
GAJEWSKI J
LEE M
HO W
TERRITO M
CHAMPLIN R
Citation: G. Schiller et al., EFFECT OF INDUCTION CYTARABINE DOSE INTENSITY ON LONG-TERM SURVIVAL IN ACUTE MYELOGENOUS LEUKEMIA - RESULTS OF A RANDOMIZED, CONTROLLED-STUDY, Leukemia & lymphoma, 11(1-2), 1993, pp. 69-77
Authors:
SCHILLER G
LEE M
TERRITO M
GAJEWSKI J
NIMER S
Citation: G. Schiller et al., PHASE-II STUDY OF ETOPOSIDE, IFOSFAMIDE, AND MITOXANTRONE FOR THE TREATMENT OF RESISTANT ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, American journal of hematology, 43(3), 1993, pp. 195-199
Authors:
GAJEWSKI J
GOODMAN LA
OROURKE S
HUNT L
LANDAW E
SCHILLER G
TERRITO M
NIMER S
FEIG S
Citation: J. Gajewski et al., AGE-RELATED SURVIVAL AND ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) INCIDENCE OF UNRELATED DONOR BONE-MARROW TRANSPLANTS FOR ADVANCED LEUKEMIAAND MYELODYSPLASIA, Experimental hematology, 21(8), 1993, pp. 1106-1106
Authors:
SCHILLER G
FEIG S
LILL M
WOLIN M
TERRITO M
HUNT L
GAJEWSKI J
Citation: G. Schiller et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FROM UNRELATED DONORS FOR PATIENTS WITH RESISTANT ACUTE-LEUKEMIA, Blood, 82(10), 1993, pp. 10000078-10000078
Authors:
SAHEBI F
BOLWELL B
CRILLEY P
FRANE M
TERRITO M
GAJEWSKI J
COPELAN E
Citation: F. Sahebi et al., UNRELATED ALLOGENEIC BONE-MARROW TRANSPLANTATION USING HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE (BU-CY) CONDITIONING REGIMEN, Blood, 82(10), 1993, pp. 10000081-10000081